Abstract | PURPOSE: To assess a correlation between the shrinkage of the fibroid and the course of the symptoms. MATERIAL AND METHODS: Fourteen patients with symptomatic uterine leiomyomas (mean fibroid volume: 111.45 cm3) underwent percutaneous microwave ablation. Contrast-enhanced MRI follow-up was performed before and after treatment to evaluate the volume shrinkage. Two scores obtained from the Uterine Fibroids Symptom and Quality of Life questionnaire were used to perform a clinical follow-up to evaluate the symptoms and the quality of life at baseline, and at 3, 6 and 12 months after treatment. RESULTS: All patients were treated, no complications occurred. During a mean MR follow-up of 8.1 months we observed shrinkage of the fibroids in all patients (mean 70.3 cm3). During 12 months clinical follow-up, we observed a significant improvement of symptoms and an excellent improvement of quality of life (p < .001). CONCLUSION:
Uterine fibroids percutaneous microwave ablation is a safe tool to obtain a significant improvement in quality of life for all the patients of our cohort.
|
Authors | Anna Maria Ierardi, Mario Petrillo, Enrico Maria Fumarola, Andrea Coppola, Salvatore Alessio Angileri, Enrico Garanzini, Salvatore Silipigni, Filippo Pesapane, Anna Maria Marconi, Gianpaolo Carrafiello |
Journal | Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
(Minim Invasive Ther Allied Technol)
Vol. 30
Issue 1
Pg. 33-39
(Feb 2021)
ISSN: 1365-2931 [Electronic] England |
PMID | 31553249
(Publication Type: Journal Article)
|
Topics |
- Female
- Humans
- Leiomyoma
(surgery)
- Microwaves
- Quality of Life
- Treatment Outcome
- Uterine Neoplasms
(surgery)
|